Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate Immunogenicity and Safety of TVAX-008 Injection in Non/Treated Chronic Hepatitis B Patients With HBsAg≤20IU/ml or HBsAg Negative Without Serological Conversion

NCT07204236 is registered in ClinicalTrials.gov with Grand Theravac Life Sciences (Nanjing) Co., Ltd. as lead sponsor.

NCT NCT07204236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07204236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate Immunogenicity and Safety of TVAX-008 Injection in Non/Treated Chronic Hepatitis B Patients With HBsAg≤20IU/ml or HBsAg Negative Without Serological Conversion
Lead sponsor
Grand Theravac Life Sciences (Nanjing) Co., Ltd.
Phase
Phase 1
Overall status
Active, not recruiting
Start date
January 18, 2024
Completion date
March 1, 2026
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b